Cargando…

Radiomic Analysis of Tumour Heterogeneity Using MRI in Head and Neck Cancer Following Chemoradiotherapy: A Feasibility Study

OBJECTIVES: To evaluate interval changes in heterogeneity on diffusion-weighted apparent diffusion coefficient (ADC) maps and T1-weighted post-gadolinium (T1w post gad) MRI in head and neck carcinoma (HNSCC), with and without chemo-radiotherapy (CRT) response. METHODS: This prospective observational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guha, Amrita, Anjari, Mustafa, Cook, Gary, Goh, Vicky, Connor, Steve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886142/ https://www.ncbi.nlm.nih.gov/pubmed/35242703 http://dx.doi.org/10.3389/fonc.2022.784693

Ejemplares similares

The impact of Human Papilloma Virus status on the prediction of head and neck cancer chemoradiotherapy outcomes using the pre-treatment apparent diffusion coefficient
por: Connor, Steve, et al.
Publicado: (2022)

Apparent diffusion coefficient agreement and reliability using different region of interest methods for the evaluation of head and neck cancer post chemo-radiotherapy
por: Anjari, Mustafa, et al.
Publicado: (2021)

Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
por: Connor, Steve, et al.
Publicado: (2021)

The ability of post-chemoradiotherapy DWI ADC(mean) and (18)F-FDG SUV(max) to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status
por: Connor, S., et al.
Publicado: (2021)

MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?
por: Connor, S. E. J., et al.
Publicado: (2021)

Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer
por: Vallières, Martin, et al.
Publicado: (2017)

Chemoradiotherapy for Head and Neck Cancer
por: D’Onofrio, Ida, et al.
Publicado: (2023)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
por: Balermpas, P, et al.
Publicado: (2014)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
por: Balermpas, P, et al.
Publicado: (2014)

Challenges and Promises of PET Radiomics
por: Cook, Gary J.R., et al.
Publicado: (2018)

Radiomics in esophageal and gastric cancer
por: Sah, Bert-Ram, et al.
Publicado: (2019)

Feasibility and Efficacy of Inspiratory Muscle Training in Patients with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy
por: Vira, Prina, et al.
Publicado: (2021)

Radiomics in Head and Neck Cancer Outcome Predictions
por: Gonçalves, Maria, et al.
Publicado: (2022)

Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of (18)F-FDG PET
por: Cook, Gary J. R., et al.
Publicado: (2017)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Feasibility of Non-invasive Brain Modulation for Management of Pain Related to Chemoradiotherapy in Patients with Advanced Head and Neck Cancer
por: Hu, Xiao-Su, et al.
Publicado: (2016)

Feasibility of a supervised and home‐based tailored exercise intervention in head and neck cancer patients during chemoradiotherapy
por: Kok, Annemieke, et al.
Publicado: (2022)

Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers
por: Giraud, Paul, et al.
Publicado: (2019)

Application of radiomics and machine learning in head and neck cancers
por: Peng, Zhouying, et al.
Publicado: (2021)

Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers
por: Gul, Maryam, et al.
Publicado: (2021)

Current Role of Delta Radiomics in Head and Neck Oncology
por: Marcu, David C., et al.
Publicado: (2023)

CT and MRI of head and neck cutaneous lesions
por: Gan, Jason, et al.
Publicado: (2023)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer
por: Müller von der Grün, Jens, et al.
Publicado: (2018)

Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy
por: Marcu, Loredana G., et al.
Publicado: (2021)

Weight Loss in Post-Chemoradiotherapy Head and Neck Cancer Patients
por: Abu Zaid, Zalina, et al.
Publicado: (2022)

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
por: Mes, Steven W., et al.
Publicado: (2020)

Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer
por: Cooke, S L, et al.
Publicado: (2011)

Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022)

A Prospective, Longitudinal and Exploratory Study of Head and Neck Lymphoedema and Dysphagia Following Chemoradiotherapy for Head and Neck Cancer
por: Jeans, Claire, et al.
Publicado: (2022)

Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy
por: Xie, Congying, et al.
Publicado: (2019)

Heterogeneity of Cancer Stem Cells in Tumorigenesis, Metastasis, and Resistance to Antineoplastic Treatment of Head and Neck Tumours
por: Cirillo, Nicola, et al.
Publicado: (2021)

Change of Swallowing in Patients With Head and Neck Cancer After Concurrent Chemoradiotherapy
por: Kweon, Sehi, et al.
Publicado: (2016)

A preliminary Study on the Effect of Head and Neck Chemoradiotherapy on Systematic Immunity
por: Huang, Weiqiang, et al.
Publicado: (2019)

Nutritional interventions in patients with head and neck cancer undergoing chemoradiotherapy: Current practice at the Dutch Head and Neck Oncology centres
por: Kok, Annemieke, et al.
Publicado: (2021)

Prediction of Incomplete Response of Primary Tumour Based on Clinical and Radiomics Features in Inoperable Head and Neck Cancers after Definitive Treatment
por: Kaźmierska, Joanna, et al.
Publicado: (2022)

The Heterogeneity of Skewness in T2W-Based Radiomics Predicts the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Coppola, Francesca, et al.
Publicado: (2021)

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
por: Tobias, Jeffrey S, et al.
Publicado: (2009)

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
por: Parmar, Chintan, et al.
Publicado: (2015)

The importance of feature aggregation in radiomics: a head and neck cancer study
por: Fontaine, Pierre, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6lkgbjlihmge51clgb4gbb8576